JAK2 and non-small cell lung carcinoma: Toward identifying the enrichment of the JAK/STAT signaling pathway based on our KEGG pathway analysis, we determined the decreased phosphorylation of JAK2 and STAT3 in PRDM5‐overexpressing A549 cells, which was in accord with the previous results in NSCLC patients.20